Exploration of baseline and early changes in neurocognitive characteristics as predictors of treatment response to bupropion, sertraline, and placebo in the EMBARC clinical trial

Yuen Siang Ang, Gerard E. Bruder, John G. Keilp, Ashleigh Rutherford, Daniel M. Alschuler, Pia Pechtel, Christian A. Webb, Thomas Carmody, Maurizio Fava, Cristina Cusin, Patrick J. McGrath, Myrna Weissman, Ramin Parsey, Maria A. Oquendo, Melvin G. McInnis, Crystal M. Cooper, Patricia Deldin, Madhukar H. Trivedi, Diego A. Pizzagalli